CHI’s Next Generation Dx Summit introduces its Inaugural Applications of Digital Pathology: Preparing for a Fully Digital Workflow conference

It is an exciting time in the world of digital pathology, with the global market value projected to reach $7,561.1 million by 2022. Currently, industry experts are evaluating the early performance of the first FDA-approved platform. While the FDA may have approved of the first digital pathology platform for primary diagnosis, the field itself requires collaboration and innovation to advance digital platforms into mainstream use in pathology.

CHI’s Next Generation Dx Summit is proud to introduce its Inaugural Applications of Digital Pathology: Preparing for a Fully Digital Workflow conference, August 20-21, 2019 in Washington DC.  The conference features a track dedicated to three aspects of this vibrant digital pathology community: AI and machine learning for digital pathology, implementing telepathology worldwide, and applications in primary diagnosis. Speakers from around the world will discuss innovation in the field and collaborate on problem-solving for issues that remain.

To view the full agenda, please visit http://bit.ly/2LQNP9b

We hope you’ll join what will be a dynamic meeting with thought-leaders and innovators. Discover the power and potential of digital pathology on a global scale and take part in the process to bring us closer to the future of medicine.

REGISTER TODAY 

Source: Next Generation Dx Summit